Animal Feeds and Feed Premixes Containing Betaine Hydrochloride and a Phytase

A SYSTEM AND METHOD FOR COMPARTMENTALIZED INGREDIENTS FOR A LIQUID PHARMACEUTICAL FORMULATION

COMPOSITIONS FOR PREVENTING TRANSITION FROM ACUTE TO CHRONIC PAIN

SYSTEM AND METHOD FOR WOUND TREATMENT AND IRRIGATION

METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING LOSS AND/OR DISTORTION OF TASTE OR SMELL

APPLICATION OF RAMAN SPECTROSCOPY FOR THE MANUFACTURE OF INHALATION POWDERS

CLINICAL WORKFLOW FOR TREATMENT OF BREAST CANCER

PREDICTIVE MARKERS FOR IMMUNOTHERAPY

USE OF ANTISENSE OLIGONUCLEOTIDE IN PREPARATION OF DRUG FOR TREATING DISEASE CAUSED BY ABNORMAL THYROID

STAT3 TARGETING OLIGONUCLEOTIDES AND USES THEREOF

PHOSPHATIDYLSERINE TARGETING MOLECULE COMBINED WITH MEMORY T CELL ANTIGEN FOR THERAPEUTIC, DIAGNOSTIC AND ADJUVANT USE

METHODS AND COMPOSITIONS FOR TREATING EOSINOPHIL DRIVEN DISEASES AND DISORDERS

ANTI-CCR8 ANTIBODIES AND USES THEREOF

USE OF ANTI-FAM19A5 ANTIBODIES FOR TREATING CANCERS

THERAPEUTIC MODULATION OF GENES IN MYELOID LINEAGE CELLS AND USES THEREOF IN OPHTHALMOLOGY

SALTS AND PHARMACUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS

COMPOUNDS AND METHODS FOR TREATING CANCER

3-AMINO-4H-BENZO[E][1,2,4]THIADIAZINE 1,1-DIOXIDE DERIVATIVES AS INHIBITORS OF MRGX2

DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

HOMEOPATHIC COMPLEX

GLYCAN PROGRAMMED CELL THERAPY

METHODS AND COMPOSITIONS FOR USE IN CELL THERAPY OF NEOPLASTIC DISEASE

COMPOSITIONS AND METHODS FOR EYE DISEASES

METHODS AND COMPOSITIONS FOR TREATING CITRUS GREENING DISEASE

METHODS AND COMPOSITIONS FOR TREATING PLANT PATHOGENS

ICAM-1 TARGETED CAR CONSTRUCTS AND METHODS OF TREATMENT

Nutritional or Dietary Supplement to Enhance Regenerative Medicine Therapies

METHODS FOR TREATING SEXUAL DYSFUNCTION ASSOCIATED WITH POLYCYSTIC OVARY SYNDROME (PCOS) OR WITH HYPOACTIVE SEXUAL DESIRE DISORDER (HSDD)

METHODS FOR DECREASING THE INCIDENCE OF NECROTIZING ENTEROCOLITIS IN INFANTS, TODDLERS, OR CHILDREN USING HUMAN MILK OLIGOSACCHARIDES

USES OF FARNESOID X RECEPTOR AGONISTS

METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME

COMBINATIONS COMPRISING POSITIVE ALLOSTERIC MODULATORS OR ORTHOSTERIC AGONISTS OF METABOTROPIC GLUTAMATERGIC RECEPTOR SUBTYPE 2 AND THEIR USE

METHODS OF TREATING A VIRUS INFECTION AND METHODS OF INHIBITING VIRAL REPLICATION

METHOD FOR REDUCING SIDE EFFECTS FROM ADMINISTRATION OF PHOSPHODIESTERASE-4 INHIBITORS

SYSTEMS AND METHODS TO IMPROVE EXERCISE TOLERANCE

METHODS AND COMPOSITIONS TO TREAT AND PREVENT VIRAL INFECTIONS AND ACUTE RESPIRATORY DISTRESS SYNDROME

METHODS AND COMPOSITIONS FOR PAIN MANAGEMENT

TREATMENT OF FRAGILE X SYNDROME AND AUTISM SPECTRUM DISORDER WITH CANNABIDIOL

Microemulsion Pharmaceutical Composition For Treatment Of Disorders Of The Anterior Segment Of The Eye

USE OF CELL MEMBRANE-BOUND SIGNALING FACTORS

MULTI CHAMBER FLEXIBLE BAG AND METHODS OF USING SAME

ALPHA DEFENSIN ASSAY FOR DIAGNOSING NOSOCOMIAL VENTRICULITIS

FOXC1 EXPRESSION AS A COMPLEMENTARY DIAGNOSTIC ASSAY FOR PREDICTING EFFICACY OF ONCOLOGY DRUGS AND DRUG COMBINATION REGIMENS AND METHODS FOR USE

PREVENTION OF DIABETES BY ENHANCEMENT OF IMMUNE MODULATION

PHARMACEUTICAL COMBINATION AND USE THEREOF

ANTI-TREM2 ANTIBODIES AND METHODS OF USE

TGF-BETA INHIBITORS AND USE THEREOF

INHIBITORS OF COMPLEMENT FACTOR H

COMPOSITIONS COMPRISING AN INTERLEUKIN CONSTRUCT

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

CHEMICAL SYNTHESIS METHOD FOR DISACCHARIDE FRAGMENT OF VIBRIO VULNIFICUS BIOTYPE 2 SEROVAR A O-ANTIGEN

LIPID COMPOUNDS AND LIPID NANOPARTICLE COMPOSITIONS

COMPOSITIONS FOR TREATING AND/OR PREVENTING CELL OR TISSUE NECROSIS SPECIFICALLY TARGETING CATHEPSIN C AND/OR CELA1 AND/OR CELA3A AND/OR STRUCTURALLY RELATED ENZYMES THERETO

2-(2-ETHOXY-4-(ETHYLTHIO)-5-METHOXYPHENYL)ETHAN-1-AMINIUM CHLORIDE

METHODS FOR MAKING AND USING ENDOXIFEN

CHEMICALLY AND PHOTOCHEMICALLY INITIATED CELL MEMBRANE BLEBBING TO INDUCE CELL VESICLE PRODUCTION, MODIFICATIONS THEREOF, AND USES THEREOF

PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION

METHODS FOR TREATING NEOPLASTIC DISEASES

Methods and Compositions for Oral Administration of Proteins

Treatment of Myasthenia Gravis with Zilucoplan

COMPOSITIONS AND METHODS FOR HAIR TREATMENT

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF PULMONARY HYPERTENSION

ANTIMICROBIAL COMPOSITIONS COMPRISING EXTRACELLULAR VESICLES AND METHODS THEREOF

PREVENTION OF AUTOIMMUNE DIABETES

METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS

TREATMENT OF DISEASES AND CONDITIONS OF THE EYE

CALCIUM OR MAGNESIUM CHLORIDE SALT-BASED COMPOSITION

BUFFERING AGENT-CONTAINING COMPOSITIONS AND METHODS OF USING SAME

SEQUENTIAL HORMONE THERAPY TO IMPROVE SURVIVAL AND ENHANCE RESPONSE TO IMMUNE THERAPY IN MEN WITH PROSTATE CANCER

Method for improving insulin insensitivity

METHODS FOR INHIBITING INFLAMMATION AND PROGRESSION OF ATHEROSCLEROTIC PLAQUES AND CARDIOVASCULAR EVENTS IN PATIENTS WITH CEREBRO- AND CARDIO-VASCULAR DISEASE

NEW CRYSTALLINE FORMS OF SALT OF 7-CYCLOPENTYL-2-(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE -6-CARBOXYLIC ACID DIMETHYLAMIDE

DUAL FUNCTIONING IMMUNE MODULATING COMPOUNDS, FORMULATIONS, AND USES THEREOF

CDK INHIBITORS

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES

NALTREXONE FOR BOOSTING THE THERAPEUTIC UTILTY OF 5-HT RECEPTOR AGONISTS

TREATMENT OF CNS CONDITIONS

TOPICAL ROFLUMILAST FORMULATION HAVING IMPROVED DELIVERY AND PLASMA HALF- LIFE

COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE AND FUSOBACTERIA-CAUSED OR RELATED DISEASES AND CONDITIONS

USE OF CLOPIDOGREL OR COMBINATIONS THEREOF TO TREAT AMYOTROPHIC LATERAL SCLEROSIS, DAMAGES CAUSED BY THE NORMAL AGING PROCESS, NERVE INJURIES, MUSCULAR DYSTROPHY, STRENUOUS PHYSICAL ACTIVITIES AND OTHER CONDITIONS THAT AFFECT SYNAPSES AS WELL AS SKELETAL MUSCLES

METHODS OF IMPROVING RENAL FUNCTION

PEPTIDE PHARMACEUTICALS FOR TREATMENT OF NASH AND OTHER DISORDERS

SIGMA-1 RECEPTOR AGONIST SYSTOLIC BLOOD PRESSURE THERAPY

COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER IN STANDARD OF CARE AND/OR PROFIBROTIC CHEMOTHERAPEUTIC AGENT-NAÏVE PATIENTS USING TUMOR TREATING FIELDS AND CHEMOTHERAPEUTIC AGENTS

COMPOSITIONS AND METHODS USING AT LEAST ONE GLYCINE OR DERIVATIVE THEREOF AND/OR AT LEAST ONE N-ACETYLCYSTEINE OR DERIVATIVE THEREOF, AND AT LEAST ONE THYMOL AND/OR CARVACROL

METHODS OF TREATMENT OF CHOLESTATIC DISEASES

VESICLES AND USES THEREOF

MESOPOROUS SILICA NANOPARTICLES WITH LIPID BILAYER COATING FOR CARGO DELIVERY

METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION

ADMINISTRATION OF BENZODIAZEPINE COMPOSITIONS

COMPOSITIONS AND THEIR USE

SKIN BIOMARKER

SQSTM1 AND ITS USE IN CANCER THERAPY

METHODS AND COMPOSITIONS FOR TREATING A PROPROTEIN CONVERTASE SUBTILISIN KEXIN (PCSK9) GENE-ASSOCIATED DISORDER

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS ASSOCIATED WITH INFECTIOUS DISEASE

TREATMENT OF METASTATIC BREAST CANCER

TARGETING AGENT

ANTI-GDF-15 ANTIBODIES

CWP2 PROTEIN AS AN EFFECTIVE VACCINE AGAINST CLOSTRIDIOIDES DIFFICILE INFECTION

ENGINEERED ANTIMICROBIAL AMPHIPHILIC PEPTIDES AND METHODS OF USE

PROCESSES FOR THE PREPARATION OF SOLUBLE SALTS OF INOSITOL PHOSPHATES

COMPOUNDS AND METHODS FOR MODULATING HER2

TRICYCLIC QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS

ADMINISTRATION REGIME FOR NITROCATECHOLS

CO-DELIVERY OF INHIBITORY NUCLEIC ACIDS AND GENOME EDITORS FOR TUMOR THERAPY

ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

METHODS, COMPOSITIONS AND COMPOUNDS FOR TREATING AGE-RELATED DISEASES AND CONDITIONS

THERAPEUTIC METHODS AND AGENTS FOR THE TREATMENT OF MYOCARDIAL INFARCTION

HISTATIN COMBINATIONS AND METHODS FOR TREATING OR INHIBITING CELL LOSS

ANTIBACTERIAL POLYPEPTIDES

EOM613 FOR TREATMENT OF COVID-19

CAR CONSTRUCTS AND METHODS OF TREATMENT

Cells Modified by Conjugated N-Terminal Glycine and Uses Thereof

Particles with RNA Cleaving Nucleobase Polymers and Uses for Managing Inflammatory Disorders

COMBINATION OF A KETONE BODY OR KETOGENIC COMPOUND WITH AN ANALGESIC OR ANTIOXIDANT

HOMOHARRINGTONINE AND PACLITAXEL COMBINATION FOR THE TREATMENT OF BREAST CANCER

TREATMENT OF HAIR LOSS DISORDERS WITH DEUTERATED JAK INHIBITORS

CDK INHIBITORS

CDK INHIBITORS

DRY EYE TREATMENTS

TREATMENT FOR NON-ALCOHOLIC FATTY LIVER DISEASE

4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS

DRUGS TARGETING INFLAMMATION FOR THE TREATMENT OF OSTEOARTHRITIS AND OTHER INFLAMMATORY DISEASES

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

COMPOUNDS FOR TREATING TNBC

STING AGONISTS, FORMULATIONS, AND USES THEREOF

METHOD FOR TREATING CANCERS AND NEUROLOGICAL DISEASES USING QUERCETIN-CONTAINING COMPOSITIONS

MEDICAMENTS FOR SLOWING PARKINSON'S DISEASE

TREATMENT OF NEUROFIBROMATOSIS TYPE 1 (NF1) ASSOCIATED PLEXIFORM NEUROFIBROMAS (PN) IN PEDIATRIC PATIENTS WITH MIRDAMETINIB

Anticholinergic Agents and Muscarinic Agonists for the Treatment of Demodex Related Conditions

SINGLE LAYER CHEWABLE TABLET COMPRISING CETIRIZINE

COMPOSITIONS FOR TOPICAL TREATMENT OF MICROBIAL INFECTIONS

ANTI-CANCER AGENTS

STRETCHABLE SELF-HEALING HYDROGEL

Subcutaneous Formulations Of Anti-CD38 Antibodies And Their Uses

METHODS OF TREATING LUNG CANCER BY ADMINISTERING A PD-1 INHIBITOR

CANCER THERAPY TARGETING NKG2A

PHARMACEUTICAL COMBINATION AND USE THEREOF

ANTIBODY MOLECULES AND USES THEREOF

THERAPEUTIC VARIANT ALPHA-2-MACROGLOBULIN COMPOSITIONS

POLYMER ENGINEERED FORMS OF INTERFERON-GAMMA AND METHODS OF USE

CAPSID INHIBITORS FOR THE PREVENTION OF HIV

QUINOLONE BCL6 BIFUNCTIONAL DEGRADERS

Ester Substituted Ion Channel Blockers and Methods for Use

KETONE INHIBITORS OF LYSINE GINGIPAIN

CYCLIC DICHALCOGENIDE ADC LINKER UNITS AND USES THEREOF

TOPICAL TETRACYCLINE COMPOSITIONS

REPROGRAMMING CD4 T CELLS INTO CYTOTOXIC CD8 CELLS BY FORCED EXPRESSION OF CD8aB AND CLASS 1 RESTRICTED T CELL RECEPTORS

ASSESSING AND TREATING CANCER

SYSTEMS, DEVICES AND METHODS FOR APPLYING ANTI-VEGF COMPOUNDS AND USING SUCH COMPOUNDS TO TREAT SKIN CONDITIONS

Afucosylated Anti-FGFR2IIIB Antibodies

IMMUNOGENIC COMPOSITIONS FOR TREATMENT OF HEPATITIS B

METHODS FOR TREATING, AMELIORATING OR PREVENTING INFECTIONS USING DRUG AND VACCINATION COMBINATION TREATMENT

METHODS OF TREATMENT FOR CANDIDA AURIS INFECTIONS

COMPOSITIONS AND METHODS FOR PROTECTING TYPE 2 ALVEOLAR EPITHELIAL CELLS (AEC2)

COLLAGEN PEPTIDE-BASED MEDICAMENT COMPOSITIONS AND DEVICES AND METHODS OF PRODUCTION AND USE THEREOF

MODIFIED MICROORGANISMS EXPRESSING SagA AND RELATED COMPOSITIONS FOR IMMUNOMODULATION AGAINST INFECTION AND CANCER IMMUNOTHERAPY

COMMENSAL BACTERIA PROMOTE ENDOCRINE-RESISTANCE IN PROSTATE CANCER VIA ANDROGEN BIOSYNTHESIS

METHOD OF TREATING CNS DISORDERS WITH NEUROSTEROIDS AND GABAERGIC COMPOUNDS

THERAPEUTIC METHODS

3-(Hydroxy)-Pyridin-4(1H)-One Compounds and Methods of Making and Using the Same

TREATMENT OF HIDRADENITIS SUPPURATIVA WITH ORISMILAST

NON-LINEAR DOSING OF MIRDAMETINIB

METHODS AND COMPOSITIONS FOR THE TREATMENT OF DEMYELINATING DISORDERS

Trans-Epithelial Membrane Drug Delivery System

PROMOTING TRAINED IMMUNITY WITH THERAPEUTIC NANOBIOLOGIC COMPOSITIONS

COMBINED MEDICINAL DRUG INCLUDING LIPOSOME COMPOSITION ENCOMPASSING TOPOTECAN OR SALT THEREOF AND DNA DAMAGE REPAIR INHIBITOR

DELIVERY SYSTEM USING ENGINEERED EXTRACELLULAR VESICLES

VASCULAR STENT AND MANUFACTURING PROCESS THEREFOR

TOPICAL ANTISEPTIC SYSTEM

PHARMACEUTICAL COMBINATIONS FOR TREATMENT OF HBV

Linkage Modified Oligomeric Compounds

MAMMALIAN CELL POPULATION AND MENDICAMENTS FOR CELL THERAPIES IN EQUINES AND IMPROVED CELL CULTIVATION METHODS

Neutrophil-Activating Therapy for the Treatment of Cancer

ANTI-CD40L ANTIBODIES AND METHODS FOR TREATING CD40L-RELATED DISEASES OR DISORDERS

ANTIBODIES, USES & METHODS

ANTI-EGFR ANTIBODY DRUG CONJUGATES

METHODS TO MANIPULATE ALPHA-FETOPROTEIN (AFP)

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

DOSAGE REGIMENS FOR TREATING MULTIFOCAL MOTOR NEUROPATHY (MMN)

TREATING REFRACTORY MIGRAINE

BISPECIFIC BINDING AGENT

THERAPEUTICALLY ACTIVE STEROIDAL DERIVATIVES

TERTIARY AMIDE DERIVATIVES SUBSTITUTED WITH 4-MEMBERED RING STRUCTURE

3,4-DIHYDRO-2,7-NAPHTHYRIDINE-1,6(2H,7H)-DIONES AS MEK INHIBITORS

NK3 MODULATORS AND USES THEREOF

CRYSTALLINE PHARMACEUTICALLY ACCEPTABLE SALT AND POLYMORPHIC FORM OF THE GLUTAMINYL CYCLASE INHIBITOR VAROGLUTAMSTAT

NOVEL INHIBITORS OF GUANOSINE MONOPHOSPHATE SYNTHETASE AS THERAPEUTIC AGENTS

Charged Ion Channel Blockers and Methods for Use

Charged Ion Channel Blockers and Methods for Use

CRYSTALLINE 4-(ETHYLSULFONYLOXY)-N,N-DI-N-PROPYLTRYPTAMMONIUM CHLORIDE

FLUOROCHEMICAL TARGETED THERAPIES

METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER

SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF

METHODS FOR TREATING AND PREVENTING NEUTROPHIL-DERIVED NET TOXICITY AND THROMBOSIS

PEPTIDES AND METHODS OF USE THEREOF IN TREATING SKIN DISEASES

HUMAN T CELL RECEPTORS SPECIFIC FOR ANTIGENIC PEPTIDES DERIVED FROM MITOGEN-ACTIVATED PROTEIN KINASE 8 INTERACTING PROTEIN 2 (MAPK8IP2), EPSTEIN-BARR VIRUS OR HUMAN ENDOGENOUS RETROVIRUS, AND USES THEREOF

ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES

Anti-FOLR1 Immunoconjugate Dosing Regimens

INTERMITTENT DOSING REGIMEN FOR AZENOSERTIB IN TREATING CANCER

COMBINATION THERAPIES

USES OF FATTY ACID AMIDE HYDROLASE INHIBITORS IN TREATMENT OF TRAUMA RELATED PSYCHIATRIC DISORDERS

METHODS OF TREATING ERYTHROPOIETIC PROTOPORPHYRIA, X-LINKED PROTOPORPHYRIA, OR CONGENITAL ERYTHROPOIETIC PORPHYRIA WITH GLYCINE TRANSPORT INHIBITORS

TREATMENT OF AUTOIMMUNE SKIN DISEASE

PHARMACEUTICAL FORMULATIONS COMPRISING NITROCATECHOL DERIVATIVES AND METHODS OF MAKING THEREOF

Beverage Composition and Process

COMPOSITIONS AND METHODS FOR STIMULATING VENTILATORY AND/OR RESPIRATORY

FATTY ACID COMPOSITIONS

DEVICES, SYSTEMS, KITS, AND METHODS FOR DRUG DELIVERY TO THE SPINAL CORD

AEROSOL FORMULATION FOR COPD

COMPOSITIONS AND METHODS FOR TREATING PTERYGIUM RECURRENCE

INJECTABLE AND INHALABLE FORMULATIONS

COMPOSITION AND METHOD FOR INHIBITING EXPRESSION OF PROTEIN LPA(APO(A))

ANTI-ROR1 ANTIBODIES

HIGH-AFFINITY, ISOFORM-SELECTIVE TGFß1 INHIBITORS AND USE THEREOF

ANTIBODIES OR ANTIGEN-BINDING FRAGMENTS PAN-SPECIFICALLY BINDING TO GREMLIN-1 AND GREMLIN-2 AND USES THEREOF

ANTI-CLEAVAGE MUTANT OF CD16 FOR ENHANCING CELL FUNCTION

ORGANIC ANION LITHIUM IONIC COCRYSTAL COMPOUNDS AND COMPOSITIONS

INDUCERS OF INTEGRATED STRESS RESPONSE TO TREAT CANCER

MCT4 INHIBITORS FOR TREATING DISEASE

METHYL SUBSTITUTED QUATERNARY TRYPTAMINE DERIVATIVES

BIOORTHOGONAL COMPOSITIONS

CORN PHYTOGLYCOGEN FORMULATIONS FOR STABILIZING PROTEINS

RAS INHIBITORS

CLICK CHEMISTRY HLA POLYPEPTIDES

TREATMENT OF POST-BARIATRIC HYPOGLYCEMIA WITH GLP-1 ANTAGONIST EXENDIN(9-39)

Granulocyte-Colony Stimulating Factor For The Promotion Of Scarless Tissue Regeneration

METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH

COMPOSITIONS FOR IMPROVING HEALTH

COMPOSITIONS AND METHODS FOR TUMOR IMMUNOTHERAPY

INHIBITORS OF EIF4A

PHARMACEUTICAL COMPOSITION INJECTABLE INTO URINARY TRACT ORGAN CAVITY FOR PREVENTION OR TREATMENT OF UROTHELIAL CANCER

METHODS FOR TREATMENT SELECTION FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS

Cancer Treatment

RESTORING FUNCTION OF SPECIFIC MUTATIONS AFFECTING THE ACTIN DYNAMIC BY ADMINISTRATION OF SAPROPTERIN

SYSTEMS AND METHODS FOR TREATING CANCER

USES OF FATTY ACID AMIDE HYDROLASE INHIBITORS IN TREATMENT OF TRAUMA RELATED PSYCHIATRIC DISORDERS

METHODS OF TREATING OCULAR CONDITIONS

HUMAN THERAPEUTIC AGENTS

PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS

COMPOSITIONS AND METHODS FOR TREATING PULMONARY DISORDERS

METHODS FOR TREATING CYTOKINE STORM ASSOCIATED WITH ACINETOBACTER BAUMANNII INFECTIONS

COMBINATION OF A SELECTIVE HISTONE DEACETYLASE 3 (HDAC3) INHIBITOR AND AN IMMUNOTHERAPY AGENT FOR THE TREATMENT OF CANCER

COMPOSITION AND METHOD FOR TREATMENT OF NEUROPSYCHIATRIC DISORDERS

POWDER COSMETIC CONTAINING ULTRAVIOLET WAVELENGTH-CONVERTING SUBSTANCE, AND METHOD FOR PRODUCING SAME

DIGITAL THERAPEUTIC FOR TREATMENT OF PERINATAL MOOD DISORDERS

MARKERS SELECTIVELY DEREGULATED IN TUMOR-INFILTRATING REGULATORY T CELLS

APOE GENOTYPING IN CANCER PROGNOSTICS AND TREATMENT

TAT-INDUCED CRISPR/ENDONUCLEASE-BASED GENE EDITING

ANTI-PLA2G10 ANTIBODIES AND METHODS OF USE

ANTIBODIES THAT BIND TO OX40 AND THEIR USES

ANTI-C-C MOTIF CHEMOKINE RECEPTOR 8 (CCR8) ANTIBODIES AND METHODS OF USE

TRISPECIFIC BINDING PROTEINS, METHODS, AND USES THEREOF

TRISPECIFIC BINDING PROTEINS, METHODS, AND USES THEREOF

NOVEL LILRB4 ANTIBODIES AND USES THEREOF

CHIMERIC TIM4 RECEPTORS AND USES THEREOF

COMBINATION THERAPY WITH ADP-RIBOSE BINDING PEPTIDE AND ADP-RIBOSE FOR PREVENTION OR TREATMENT OF CANCER

FUSED PYRIMIDINE DERIVATIVES AS KRAS ONCOPROTEIN INHIBITORS

IRON-ACTIVABLE NITROGEN-CONTAINING DERIVATIVES OF SALINOMYCIN AND NARASIN, SYNTHESIS AND USE FOR THE TREATMENT OF CANCERS

NITROGEN-CONTAINING DERIVATIVES OF NARASIN, SYNTHESIS AND USES THEREOF

COMPOSITIONS AND METHODS FOR INHIBITING KINASES

SALT FORMS AND POLYMORPHS OF (R)-1-(4-(6-(2-(4-(3,3-DIFLUOROCYCLOBUTOXY)-6-METHYLPYRIDIN-2-YL)ACETAMIDO) PYRIDAZIN-3-YL)-2-FLUOROBUTYL)-N-METHYL-1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE

PIPERIDINYLBENZONITRILE DERIVATIVES AS INHIBITORS OF GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE AND GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE LIKE PROTEIN

LIGAND-DRUG-CONJUGATES WITH IMPROVED PHARMACOKINETIC AND DRUG RELEASE PROPERTIES

ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

ANTIMICROBIAL PEPTIDE DERIVATIVE AND USE THEREOF

SEQUENCE SPECIFIC ANTIMICROBIALS

NAMPT FOR WOUND-HEALING AND STIMULATING HAIR GROWTH AND/OR REGROWTH

METHODS OF TREATING CANCER

COMPOSITIONS AND METHODS FOR TREATING PULMONARY HYPERTENSION

ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)

ENGRAFTMENT OF STEM CELLS WITH A COMBINATION OF AN AGENT THAT TARGETS STEM CELLS AND MODULATION OF IMMUNOREGULATORY SIGNALING

CD30 HINGE AND/OR TRANSMEMBRANE DOMAIN-BASED CHIMERIC ANTIGEN RECEPTORS

STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS

STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS

PRODUCTS AND COMPOSITIONS

DRUG DELIVERY CARRIER UTILIZING PROPERTY OF D-ALLOSE BEING UPTAKEN BY CANCER CELL, DRUG DELIVERY METHOD, AND COMPOSITION FOR TREATING RENAL CELL CARCINOMA

METHODS AND COMPOSITIONS RELATED TO GLUCOCORTICOID RECEPTOR ANTAGONISTS AND BREAST CANCER

COLLOIDALLY STABLE HEME-ALBUMIN COMPLEXES AND METHODS OF MAKING AND USING THEREOF

TREATMENT

PROTEIN KINASE C INHIBITORS FOR TREATMENT OF UVEAL MELANOMA

COMPOSITIONS AND METHODS FOR TREATING POLYCYTHEMIA

INNATE IMMUNE-ACTIVATING DRUG AND USE THEREOF

STABLE POLYMORPHIC COMPOSITIONS OF BREQUINAR SODIUM AND METHODS OF USE AND MANUFACTURE THEREOF

BOWEL CLEANSING COMPOSITION

IMMUNE MODULATORY AGENTS

TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES

Methods for Providing Rapid Relief of Motor Fluctuations in a Parkinson's Disease Patient

LIQUID-DISPERSIBLE HALOPYRUVATE FORMULATIONS AND ASSOCIATED METHODS

USE OF CANNABINOIDS IN THE TREATMENT OF EPILEPSY

Transdermal and/or Topical, Pharmaceutical Formulations Comprising Cannabidiol and/or Tetrahydrocannabinol for the Treatment of Chronic Pain

SOFTGEL CAPSULES HAVING A FILL COMPOSITION COMPRISING APPLE CIDER VINEGAR

VASOCONSTRICTION COMPOSITIONS AND METHODS OF USE

Deuterated Polyunsaturated Fatty Acids Or Esters Thereof For Cosmetic Applications

Secreted P-glycoprotein is a Non-Invasive Biomarker of Chronic Rhinosinusitis

METHODS OF DIAGNOSING AND TREATING LUNG CANCER

EX VIVO COLONIC BIOPSY PLATFORM TO EVALUATE MULTI-OMIC SIGNATURES FOR SCREENING CANDIDATE THERAPEUTICS

PNPLA3-TARGETING SHORT INTERFERING RNA (SIRNA) MOLECULES AND USES THEREOF